HS

Hashan Silva

CurveBeam AI Limited | Non-Executive Director
Mr Silva was appointed to the Board of the Company in 2021 as a nominee of Karst Peak Capital Limited (Karst Peak).Mr De Silva Is currently the Founder and Managing Partner of KP Rx, a healthcare fund manager on innovative healthcare companies based in Australia and New Zealand. Previously he held the role of head of healthcare research at Karst Peak, an investment management firm based in Sydney and Hong Kong, which has a focus on biotechnology, health technology, medical devices and diagnostics. Mr De Silva previously served as an equity research analyst in healthcare at CLSA Limited and at Macquarie Group. Mr De Silva was appointed to the board of directors of Pharmaxis Limited (ASX:PXS) in January 2023.

Company and Role

Company
Title
Tenure
Since
CVB
CurveBeam AI Limited
  • Non-Executive Director
2yrs, 7mthOct 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CVB
CurveBeam AI Limited
13/02/24565,493320,9282,339,081N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CVB
CurveBeam AI Limited
13/02/24
Issued
109,375$0.480$52,500Director remuneration
CVB
CurveBeam AI Limited
03/11/23
Buy
11,443$0.340$3,890On-market trade
CVB
CurveBeam AI Limited
25/08/23
Buy
101,265$0.396$40,130On-market trade